Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle

Department of Obstetrics and Gynecology, Faculty of Medicine, Osaka University, 2-2 Yamada-oka, Suita City, Osaka 565-0871, Japan.
Molecular Human Reproduction (Impact Factor: 3.75). 08/1999; 5(7):656-61. DOI: 10.1093/molehr/5.7.656
Source: PubMed


Secretory leukocyte protease inhibitor (SLPI) is a potent inhibitor of human leukocyte elastase. SLPI transcripts in the cervical tissue were detected during the menstrual cycle by reverse transcription-polymerase chain reaction (RT-PCR). Western blot analysis revealed that the intensity of SLPI protein in cervical tissue in the ovulatory phase was stronger than in other phases. Immunohistochemistry using an anti-SLPI polyclonal antibody revealed positive staining in the epithelial cells of the endocervix. Western blot analysis also revealed that SLPI protein was present in the cervical mucus. Again the intensity of SLPI protein in the ovulatory phase was stronger than that in the follicular phase. The SLPI concentrations and SLPI/elastase ratios in the cervical mucus of women in the ovulatory phase were significantly higher than in the follicular and luteal phases. The SLPI and elastase concentrations in the cervical mucus were positively correlated. No significant difference was found in the SLPI serum concentrations of women during the menstrual cycle. These results suggest that production of SLPI from cervical epithelial cells during the ovulatory phase may be important for protection from the effects of elastase.

Download full-text


Available from: Tadashi Kimura,
  • Source
    • "Human epithelial and myeloid cells constitutively secrete SLPI, and cellular production can be significantly upregulated in response to various stimuli [69]. Concentrations in cervical mucosal fluids are commonly reported at 1 µg/ml [70], but are likely to be more concentrated at the cell surface. In addition, SLPI levels in cervical mucus have been measured midcycle as high as 78 µg/mL [71]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mucosotropic, high-risk human papillomaviruses (HPV) are sexually transmitted viruses that are causally associated with the development of cervical cancer. The most common high-risk genotype, HPV16, is an obligatory intracellular virus that must gain entry into host epithelial cells and deliver its double stranded DNA to the nucleus. HPV capsid proteins play a vital role in these steps. Despite the critical nature of these capsid protein-host cell interactions, the precise cellular components necessary for HPV16 infection of epithelial cells remains unknown. Several neutralizing epitopes have been identified for the HPV16 L2 minor capsid protein that can inhibit infection after initial attachment of the virus to the cell surface, which suggests an L2-specific secondary receptor or cofactor is required for infection, but so far no specific L2-receptor has been identified. Here, we demonstrate that the annexin A2 heterotetramer (A2t) contributes to HPV16 infection and co-immunoprecipitates with HPV16 particles on the surface of epithelial cells in an L2-dependent manner. Inhibiting A2t with an endogenous annexin A2 ligand, secretory leukocyte protease inhibitor (SLPI), or with an annexin A2 antibody significantly reduces HPV16 infection. With electron paramagnetic resonance, we demonstrate that a previously identified neutralizing epitope of L2 (aa 108-120) specifically interacts with the S100A10 subunit of A2t. Additionally, mutation of this L2 region significantly reduces binding to A2t and HPV16 pseudovirus infection. Furthermore, downregulation of A2t with shRNA significantly decreases capsid internalization and infection by HPV16. Taken together, these findings indicate that A2t contributes to HPV16 internalization and infection of epithelial cells and this interaction is dependent on the presence of the L2 minor capsid protein.
    PLoS ONE 08/2012; 7(8):e43519. DOI:10.1371/journal.pone.0043519 · 3.23 Impact Factor
  • Source
    • "We observed that transcytosis of HIV across polarized endometrial and cervical epithelia did not affect viral infectivity (Figure 3), and this was well correlated with the absence or lowlevel expression of HBD2, HBD3, and SLPI in these cells (Figure 4). Expression of HBD2, HBD3, and SLPI in the genital mucosa was not stable and depends on the menstrual cycle, i.e., HBD3 and SLPI express during the secretory phase, and HBD2 expression has been detected only during menstruation (King, Critchley, and Kelly, 2003;King et al., 2003;Moriyama et al., 1999). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Oral transmission of human immunodeficiency virus (HIV) in adult populations is rare. However, HIV spread across fetal/neonatal oropharyngeal epithelia could be important in mother-to-child transmission. Analysis of HIV transmission across polarized adult and fetal oral epithelial cells revealed that HIV transmigrates through both adult and fetal cells. However, only virions that passed through the fetal cells - and not those that passed through the adult cells - remained infectious. Analysis of expression of anti-HIV innate proteins beta-defensins 2 and 3, and secretory leukocyte protease inhibitor in adult, fetal, and infant oral epithelia showed that their expression is predominantly in the adult oral epithelium. Retention of HIV infectivity after transmigration correlated inversely with the expression of these innate proteins. Inactivation of innate proteins in adult oral keratinocytes restored HIV infectivity. These data suggest that high-level innate protein expression may contribute to the resistance of the adult oral epithelium to HIV transmission.
    Virology 11/2010; 409(2):211-22. DOI:10.1016/j.virol.2010.10.004 · 3.32 Impact Factor
  • Source
    • "mRNA highest at menstruation (Fleming et al. 2003) mRNA highest in secretory phase (King et al. 2003b) mRNA highest in proliferative phase (King et al. 2003b) mRNA and protein highest in secretory phase (King et al. 2000) mRNA and protein highest at menstruation (King et al. 2003a) Cervix mRNA (Valore et al. 1998) Not reported Not reported Not reported Protein (Moriyama et al. 1999) Protein (Pfundt et al. 1996) Vagina mRNA (Valore et al. 1998, Narvekar et al. 2007) mRNA (Narvekar, et al. 2007) mRNA (Narvekar et al. 2007) Not reported Protein – cell line (Fichorova & Anderson 1999, Valore et al. 2006) Protein (Pfundt et al. 1996) mRNA (Narvekar, et al. 2007) Pregnant Amnion mRNA and protein (King et al. 2007) mRNA and protein (King et al. 2007, Stock et al. 2007) mRNA and protein (King et al. 2007) Not reported Protein (Zhang et al. 2001) mRNA and protein (King et al. 2007) Chorion mRNA and protein (King et al. 2007) mRNA and protein (King et al. 2007) mRNA and protein (King et al. 2007) Not reported Mainly negative (Denison et al. 1999) mRNA and protein (King et al. 2007) Placenta mRNA and protein (King et al. 2007) mRNA and protein (King et al. 2007) mRNA and protein (King et al. 2007) Not reported Mainly negative (Denison et al. 1999) mRNA and protein (King et al. 2007) Decidua mRNA and protein (King et al. 2007) mRNA and protein (King et al. 2007) mRNA and protein (King et al. 2007) Not reported mRNA and protein (Denison et al. 1999, King et al. 2000) mRNA and protein (King et al. 2007) Cervical mucus plug Protein (Hein et al. 2002) Not reported Not reported Not reported Protein (Helmig et al. 1995, Hein et al. 2002) "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sexually transmitted infections, and their associated sequelae, such as tubal infertility, ectopic pregnancy and preterm labour, are a major worldwide health problem. Chlamydia trachomatis infection is thought to be the leading global cause of tubal infertility and tubal ectopic pregnancy. Preterm birth occurs in around 10% of all deliveries, and nearly 30% of preterm deliveries are associated with intrauterine infection. The mucosal innate immune system of the female reproductive tract has evolved to eliminate such sexually transmitted pathogens whilst maintaining its ability to accommodate specialized physiological functions that include menstruation, fertilization, implantation, pregnancy and parturition. The aim of this review was to describe the role and distribution of key mediators of the innate immune system, the natural antimicrobial peptides (secretory leukocyte protease inhibitor, elafin and the defensins) and the pattern recognition toll-like receptors in the normal female reproductive tract and in the context of these pathological processes.
    Reproduction 07/2008; 135(6):739-49. DOI:10.1530/REP-07-0564 · 3.17 Impact Factor
Show more